Literature DB >> 6215083

Severe headache and disturbed liver function during treatment with zimelidine.

J M Sommerville, E H McLaren, L M Campbell, J M Watson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215083      PMCID: PMC1500311          DOI: 10.1136/bmj.285.6347.1009

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Platelet-bound and free serotonin levels in jugular and forearm venous blood during migraine.

Authors:  B W Somerville
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

2.  Zimelidine: a therapeutic and pharmacokinetic study in depression.

Authors:  A Coppen; V A Ramo Rao; C Swade; K Wood
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

3.  Decreased blood level of 5-dehydroxytryptamine by inhibitors of the membranal 5-hydroxytryptamine uptake.

Authors:  S B Ross; S Jansa; L Wetterberg; B Fyrö; B Hellner
Journal:  Life Sci       Date:  1976-07-15       Impact factor: 5.037

4.  Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients.

Authors:  B Siwers; V A Ringberger; J R Tuck; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1977-02       Impact factor: 6.875

  4 in total
  2 in total

1.  Possible hepatotoxicity of zimelidine.

Authors:  G K Simpson; N M Davidson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

Review 2.  5-Hydroxytryptamine and the pathophysiology of migraine.

Authors:  P P Humphrey
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.